There are 73 resources available
Introduction
Presenter: Bradley J. Monk
Session: ADCs in gynaecological cancers
Resources:
Webcast
Understanding the basics: Structure, key properties, mechanism of action, optimal diagnostic test to determine the target
Presenter: Kathleen Moore
Session: ADCs in gynaecological cancers
Resources:
Slides
Webcast
The evolving ADC treatment landscape in ovarian cancer
Presenter: Ilaria Colombo
Session: ADCs in gynaecological cancers
Resources:
Slides
Webcast
Role of ADCs in cervical cancer treatment in the era of immunotherapy
Presenter: Bradley J. Monk
Session: ADCs in gynaecological cancers
Resources:
Slides
Webcast
The new challenge: ADC class effects, on/off-target adverse reactions and their interdisciplinary management
Presenter: Toon Van Gorp
Session: ADCs in gynaecological cancers
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: ADCs in gynaecological cancers
Resources:
Webcast
Introduction and first vote
Presenter: Robert Coleman
Session: How hot is HIPEC treatment in ovarian cancer?
Resources:
Slides
Webcast
The data absolutely support integration of HIPEC into primary ovarian cancer management (PRO)
Presenter: Willemien Van Driel
Session: How hot is HIPEC treatment in ovarian cancer?
Resources:
Slides
Webcast
HIPEC is not "IT" (CON)
Presenter: Leslie Randall
Session: How hot is HIPEC treatment in ovarian cancer?
Resources:
Slides
Webcast
Second vote and conclusions
Presenter: Robert Coleman
Session: How hot is HIPEC treatment in ovarian cancer?
Resources:
Slides
Webcast